{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:21:41Z","timestamp":1793848901153,"version":"4.6.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jpha.2024.101132","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T06:54:55Z","timestamp":1729839295000},"page":"101132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Discovery of E0199: A novel compound targeting both peripheral NaV and KV7 channels to alleviate neuropathic pain"],"prefix":"10.1016","volume":"15","author":[{"given":"Boxuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junru","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzhong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2024.101132_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1152\/physrev.00045.2019","article-title":"Neuropathic pain: From mechanisms to treatment","volume":"101","author":"Finnerup","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jpha.2024.101132_bib2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic pain: Diagnosis, pathophysiological mechanisms, and treatment","volume":"9","author":"Baron","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jpha.2024.101132_bib3","doi-asserted-by":"crossref","first-page":"S429","DOI":"10.1093\/infdis\/jiab387","article-title":"Herpes zoster vaccines","volume":"224","author":"Harbecke","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jpha.2024.101132_bib4","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.3390\/ijms21093396","article-title":"Behavioral, biochemical and electrophysiological changes in spared nerve injury model of neuropathic pain","volume":"21","author":"Guida","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2024.101132_bib5","doi-asserted-by":"crossref","first-page":"f7656","DOI":"10.1136\/bmj.f7656","article-title":"Neuropathic pain: Mechanisms and their clinical implications","volume":"348","author":"Cohen","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jpha.2024.101132_bib6","article-title":"Peripheral voltage-gated cation channels in neuropathic pain and their potential as therapeutic targets","volume":"2","author":"Alles","year":"2021","journal-title":"Front. Pain Res. (Lausanne)"},{"key":"10.1016\/j.jpha.2024.101132_bib7","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/j.pain.0000000000001511","article-title":"The role of NaV1.7 in human nociceptors: Insights from human induced pluripotent stem cell-derived sensory neurons of erythromelalgia patients","volume":"160","author":"Meents","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.jpha.2024.101132_bib8","doi-asserted-by":"crossref","first-page":"10277","DOI":"10.1523\/JNEUROSCI.22-23-10277.2002","article-title":"Roles of tetrodotoxin (TTX)-sensitive Na+ current, TTX-resistant Na+ current, and Ca2+ current in the action potentials of nociceptive sensory neurons","volume":"22","author":"Blair","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jpha.2024.101132_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41583-021-00444-w","article-title":"The physiological function of different voltage-gated sodium channels in pain","volume":"22","author":"Goodwin","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jpha.2024.101132_bib10","doi-asserted-by":"crossref","first-page":"19444","DOI":"10.1073\/pnas.1216080109","article-title":"Gain-of-function NaV1.8 mutations in painful neuropathy","volume":"109","author":"Faber","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.jpha.2024.101132_bib11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1474-4422(14)70024-9","article-title":"Painful and painless channelopathies","volume":"13","author":"Bennett","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jpha.2024.101132_bib12","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1093\/brain\/awab482","article-title":"NaV1.7 is required for normal C-low threshold mechanoreceptor function in humans and mice","volume":"145","author":"Middleton","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.jpha.2024.101132_bib13","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/ng.2767","article-title":"A de novo gain-of-function mutation in SCN11A causes loss of pain perception","volume":"45","author":"Leipold","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jpha.2024.101132_bib14","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/brain\/awu079","article-title":"Gain-of-function mutations in sodium channel NaV1.9 in painful neuropathy","volume":"137","author":"Huang","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.jpha.2024.101132_bib15","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/j.pain.0000000000001227","article-title":"Efficacy of the NaV1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy","volume":"159","author":"McDonnell","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.jpha.2024.101132_bib16","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s40263-013-0123-5","article-title":"Lacosamide: A review of its use as adjunctive therapy in the management of partial-onset seizures","volume":"27","author":"Hoy","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpha.2024.101132_bib17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ebiom.2018.11.042","article-title":"Pain relief in a neuropathy patient by lacosamide: Proof of principle of clinical translation from patient-specific iPS cell-derived nociceptors","volume":"39","author":"Namer","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jpha.2024.101132_bib18","first-page":"CD010567","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews","volume":"2013","author":"Wiffen","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jpha.2024.101132_bib19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/aps.2017.151","article-title":"Enhancing inactivation rather than reducing activation of NaV1.7 channels by a clinically effective analgesic CNV1014802","volume":"39","author":"Zheng","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jpha.2024.101132_bib20","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/j.pain.0000000000001567","article-title":"Antiallodynic effects of the selective NaV1.7 inhibitor Pn3a in a mouse model of acute postsurgical pain: Evidence for analgesic synergy with opioids and baclofen","volume":"160","author":"Mueller","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.jpha.2024.101132_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1124\/molpharm.122.000593","article-title":"Use-dependent relief of inhibition of NaV1.8 channels by A-887826","volume":"103","author":"Jo","year":"2023","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jpha.2024.101132_bib22","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/pm\/pnab032","article-title":"A phase 1, randomized, double-blind, placebo-controlled, crossover study to evaluate the pharmacodynamic effects of VX-150, a highly selective NaV1.8 inhibitor, in healthy male adults","volume":"22","author":"Hijma","year":"2021","journal-title":"Pain Med."},{"key":"10.1016\/j.jpha.2024.101132_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e15423","article-title":"Reduced pain sensitivity of episodic pain syndrome model mice carrying a NaV1.9 mutation by ANP-230, a novel sodium channel blocker","volume":"9","author":"Okuda","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.jpha.2024.101132_bib24","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/cne.23019","article-title":"KV7.5 is the primary KV7 subunit expressed in C-fibers","volume":"520","author":"King","year":"2012","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jpha.2024.101132_bib25","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/j.pain.0000000000000368","article-title":"Potassium channels in neuropathic pain: Advances, challenges, and emerging ideas","volume":"157","author":"Busserolles","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.jpha.2024.101132_bib26","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1111\/bph.13978","article-title":"M-type K+ channels in peripheral nociceptive pathways","volume":"175","author":"Du","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpha.2024.101132_bib27","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1523\/JNEUROSCI.23-18-07227.2003","article-title":"KCNQ\/M currents in sensory neurons: Significance for pain therapy","volume":"23","author":"Passmore","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jpha.2024.101132_bib28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0014-2999(02)02924-2","article-title":"The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain","volume":"460","author":"Blackburn-Munro","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpha.2024.101132_bib29","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1002\/cne.23595","article-title":"KV7.2 regulates the function of peripheral sensory neurons","volume":"522","author":"King","year":"2014","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jpha.2024.101132_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s40272-021-00448-0","article-title":"Neurocognitive effects of antiseizure medications in children and adolescents with epilepsy","volume":"23","author":"Besag","year":"2021","journal-title":"Pediatr. Drugs"},{"key":"10.1016\/j.jpha.2024.101132_bib31","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1476-5381.2012.02232.x","article-title":"Modulation of KV7 potassium channels by a novel opener pyrazolo[1,5-a]pyrimidin-7(4H)-one compound QO-58","volume":"168","author":"Zhang","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpha.2024.101132_bib32","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/nm.3978","article-title":"Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade","volume":"21","author":"Xu","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpha.2024.101132_bib33","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.19-24-j0001.1999","article-title":"A novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons","volume":"19","author":"Cummins","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jpha.2024.101132_bib34","doi-asserted-by":"crossref","first-page":"9629","DOI":"10.1523\/JNEUROSCI.21-24-09629.2001","article-title":"Glycosylation alters steady-state inactivation of sodium channel NaV1.9\/NaN in dorsal root ganglion neurons and is developmentally regulated","volume":"21","author":"Tyrrell","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jpha.2024.101132_bib35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/toxsci\/52.2.141","article-title":"Ethical review of regulatory toxicology guidelines involving experiments on animals: The example of endocrine disrupters","volume":"52","author":"Purchase","year":"1999","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jpha.2024.101132_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/laban.604","article-title":"Approaches to animal research project evaluation in Europe after implementation of Directive 2010\/63\/EU","volume":"44","author":"Guill\u00e9n","year":"2015","journal-title":"Lab Anim. (NY)"},{"key":"10.1016\/j.jpha.2024.101132_bib37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1749-6632.2011.06335.x","article-title":"Animal welfare and the 3Rs in European biomedical research","volume":"1245","author":"Wells","year":"2011","journal-title":"Ann N. Y. Acad. Sci."},{"key":"10.1016\/j.jpha.2024.101132_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ilar\/ilac012","article-title":"Guide for laboratory animal facilities and care","volume":"62","year":"2021","journal-title":"ILAR J."},{"key":"10.1016\/j.jpha.2024.101132_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12916-022-02705-6","article-title":"Prolonged anesthesia induces neuroinflammation and complement-mediated microglial synaptic elimination involved in neurocognitive dysfunction and anxiety-like behaviors","volume":"21","author":"Xu","year":"2023","journal-title":"BMC Med."},{"key":"10.1016\/j.jpha.2024.101132_bib40","doi-asserted-by":"crossref","first-page":"22496","DOI":"10.1021\/acsomega.3c00085","article-title":"SS-GNN: A simple-structured graph neural network for affinity prediction","volume":"8","author":"Zhang","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.jpha.2024.101132_bib41","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bph.14153","article-title":"Experimental design and analysis and their reporting II: Updated and simplified guidance for authors and peer reviewers","volume":"175","author":"Curtis","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpha.2024.101132_bib42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.molmed.2021.11.005","article-title":"iPSCs and DRGs: Stepping stones to new pain therapies","volume":"28","author":"Alsaloum","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jpha.2024.101132_bib43","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1152\/physrev.00052.2017","article-title":"The role of voltage-gated sodium channels in pain signaling","volume":"99","author":"Bennett","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jpha.2024.101132_bib44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-neuro-070918-050144","article-title":"Sodium channels in human pain disorders: Genetics and pharmacogenomics","volume":"42","author":"Dib-Hajj","year":"2019","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.jpha.2024.101132_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1138556","article-title":"KV7-specific activators hyperpolarize resting membrane potential and modulate human iPSC-derived sensory neuron excitability","volume":"14","author":"Estacion","year":"2023","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.jpha.2024.101132_bib46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1146\/annurev-neuro-060909-153234","article-title":"Sodium channels in normal and pathological pain","volume":"33","author":"Dib-Hajj","year":"2010","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.jpha.2024.101132_bib47","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/brain\/awac078","article-title":"Sensory neurons have an axon initial segment that initiates spontaneous activity in neuropathic pain","volume":"145","author":"Nascimento","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.jpha.2024.101132_bib48","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/brain\/awac156","article-title":"The axon initial segment as a source of neuropathic pain","volume":"145","author":"Dorrego-Rivas","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.jpha.2024.101132_bib49","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.pain.2013.06.015","article-title":"Analgesic treatment of ciguatoxin-induced cold allodynia","volume":"154","author":"Zimmermann","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.jpha.2024.101132_bib50","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/toxins14070485","article-title":"Gambierdiscus and its associated toxins: A minireview","volume":"14","author":"Wang","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.jpha.2024.101132_bib51","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1126\/science.aaw2493","article-title":"Structures of human NaV1.7 channel in complex with auxiliary subunits and animal toxins","volume":"363","author":"Shen","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jpha.2024.101132_bib52","article-title":"Structural basis for high-voltage activation and subtype-specific inhibition of human NaV1.8","volume":"A 119","author":"Huang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U S"},{"key":"10.1016\/j.jpha.2024.101132_bib53","doi-asserted-by":"crossref","DOI":"10.1080\/19336950.2023.2287832","article-title":"A structural atlas of druggable sites on NaV channels","volume":"18","author":"Li","year":"2024","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.jpha.2024.101132_bib54","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41582-020-00415-2","article-title":"Status of peripheral sodium channel blockers for non-addictive pain treatment","volume":"16","author":"Alsaloum","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jpha.2024.101132_bib55","doi-asserted-by":"crossref","first-page":"8116","DOI":"10.1038\/ncomms9116","article-title":"Atomic basis for therapeutic activation of neuronal potassium channels","volume":"6","author":"Kim","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpha.2024.101132_bib56","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41422-020-00410-8","article-title":"Molecular basis for ligand activation of the human KCNQ2 channel","volume":"31","author":"Li","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.jpha.2024.101132_bib57","doi-asserted-by":"crossref","first-page":"10285","DOI":"10.1021\/acs.jmedchem.1c02115","article-title":"General pharmacological activation mechanism of K+ channels bypassing channel gates","volume":"65","author":"Liu","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpha.2024.101132_bib58","doi-asserted-by":"crossref","first-page":"6632","DOI":"10.1038\/s41467-023-42416-x","article-title":"Ligand activation mechanisms of human KCNQ2 channel","volume":"14","author":"Ma","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpha.2024.101132_bib59","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.3390\/molecules28134888","article-title":"Three-step synthesis of the antiepileptic drug candidate pynegabine","volume":"28","author":"Sun","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jpha.2024.101132_bib60","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/14740338.2020.1744561","article-title":"A description of medicines-related safety issues evaluated through a referral procedure at the EU level after 2012","volume":"19","author":"Farcas","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jpha.2024.101132_bib61","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1474-4422(17)30005-4","article-title":"Safety and efficacy of a NaV1.7 selective sodium channel blocker in patients with trigeminal neuralgia: A double-blind, placebo-controlled, randomised withdrawal phase 2a trial","volume":"16","author":"Zakrzewska","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jpha.2024.101132_bib62","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1073\/pnas.0611364104","article-title":"A-803467, a potent and selective NaV1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat","volume":"104","author":"Jarvis","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.jpha.2024.101132_bib63","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1111\/bph.13092","article-title":"A novel selective and orally bioavailable NaV1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitability","volume":"172","author":"Payne","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpha.2024.101132_bib64","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1039\/D0MD00328J","article-title":"Chemical modulation of KV7 potassium channels","volume":"12","author":"Borgini","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.jpha.2024.101132_bib65","article-title":"Biophysical and pharmacological characterization of NaV1.9 voltage dependent sodium channels stably expressed in HEK-293 cells","volume":"11","author":"Lin","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jpha.2024.101132_bib66","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1744-8069-9-31","article-title":"Effect of amitriptyline on tetrodotoxin-resistant NaV1.9 currents in nociceptive trigeminal neurons","volume":"9","author":"Liang","year":"2013","journal-title":"Mol. Pain"},{"key":"10.1016\/j.jpha.2024.101132_bib67","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuropharm.2017.02.010","article-title":"Loperamide inhibits sodium channels to alleviate inflammatory hyperalgesia","volume":"117","author":"Wu","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpha.2024.101132_bib68","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1124\/jpet.103.051086","article-title":"Vinpocetine is a potent blocker of rat NaV1.8 tetrodotoxin-resistant sodium channels","volume":"306","author":"Zhou","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177924002296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177924002296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T10:30:21Z","timestamp":1740652221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177924002296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2095177924002296"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2024.101132","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of E0199: A novel compound targeting both peripheral NaV and KV7 channels to alleviate neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2024.101132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Xi\u2019an Jiaotong University.","name":"copyright","label":"Copyright"}],"article-number":"101132"}}